The 36-month PFS rate for patients with del (17p) and/or TP53 mutation was 87% and for patients without del (17p) and TP53 mutation was 89%. The safety profile of BRUKINSA plus venetoclax was ...

Bigger Display. Max Clarity: A 1.5″ ultra-bright AMOLED display delivers exceptional clarity in any setting—whether in the ...

This collaboration leverages the University of Cambridge’s deep expertise in fundamental wireless technology research, ...

SC Ventures builds and invests in breakthrough ventures in and beyond banking. SC Ventures by Standard Chartered provides a ...

The new product offers a faster propagation delay than the current TC75W56FU, with a maximum of 45ns for low-to-high ...

Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for ...

IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health ...

Xsolla, a leading global video game commerce company that helps developers launch, grow, and monetize their games, today ...

Z.ai released GLM-4.7 ahead of Christmas, marking the latest iteration of its GLM large language model family. As open-source models move beyond chat-based applications and into production ...

By joining the AAIF, Liquid Reply reinforces its commitment to open-source and community-driven innovation, and supports the ...

Tabelog ( https://tabelog.com/en/ ), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., ...